Autopsy report · NCT00890149

Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults

“Difficulty recruiting target sample”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 years 5 months before it started.
• Ran for about 1 year 6 months before it stopped.
• 74 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Maryland, Baltimore

Sponsor type

University, hospital or other

Conditions

Alcohol Abuse; Alcoholism

Interventions

Ondansetron; Placebo; BASICS Plus

Participants

74

Sites

1

Countries

United States

Trials that died the same way

• Efficacy and Safety of MedifoamⓇ and BetafoamⓇ in Pressure Ulcer
  “Difficulties in meeting recruitment target” (77% match in meaning)
• Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study
  “Difficulty with meeting recruitment targets” (76% match in meaning)
• Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway
  “Target recruitment not reached” (76% match in meaning)
• Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial
  “Difficulty recruiting” (75% match in meaning)
• Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis
  “Not able to meet recruitment targets” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.